Our team has a wealth of experience and expertise in the development of protein/peptide therapeutics and an in-depth understanding of the needs of the pharmaceutical industry when it comes to the development and manufacture of novel, effective and safe biologics. In addition, with our business acumen and experience of forming strategic alliances we are working to build effective partnerships to deliver biologics solutions:
Dr Lisa Patel | Non-Exec Director
Lisa has 20 years’ experience in drug discovery and development, both as a team and group leader at GlaxoSmithKline and subsequently as Chief Scientific Officer at Istesso Limited. Lisa is Chief Scientific Officer of the Biotech portfolio at IP Group plc and serves on the Scientific Advisory Board of Avacta plc. She holds a degree in Biochemistry, a PhD in molecular genetics and an MBA.